Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BAY2862789 |
Trade Name | |
Synonyms | BAY 2862789|BAY-2862789 |
Drug Descriptions |
BAY2862789 is a DGK-alpha inhibitor, which may increase TCR signaling and enhance antitumor immune response (Journal for ImmunoTherapy of Cancer 2024;12, NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C200820 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BAY2862789 | BAY2862789 | 0 | 1 |